Difference between revisions of "Stub"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon. This page is primarily to drive the [[Ontology]]. | Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon. This page is primarily to drive the [[Ontology]]. | ||
| − | {{TOC limit|limit= | + | {{TOC limit|limit=2}} |
==Carboplatin, Etoposide, Thalidomide== | ==Carboplatin, Etoposide, Thalidomide== | ||
{| class="wikitable" style="float:right; margin-left: 5px;" | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
Revision as of 01:52, 30 July 2020
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon. This page is primarily to drive the Ontology.
Carboplatin, Etoposide, Thalidomide
| back to top |
Regimen
Chemotherapy
Targeted therapy
Ixabepilone & Bevacizumab
| back to top |
Regimen
Chemotherapy
Targeted therapy
TG+Bev
| back to top |
TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab
Regimen
Chemotherapy
Targeted therapy
TX+Bev
| back to top |
TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab